ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Will Encourage More Nutrition Research, Upton Tells McGovern

June 23, 1978

CCOPs Favor Ability To Enter Patients On Any Group Study

June 12, 1998

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998